公司概覽
業務類別 Drug Manufacturers - Specialty & Generic
業務概覽 Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
公司地址 1 Burlington Road, Connaught House, Dublin, IRL, D04 C5Y6
電話號碼 +353 17728000
傳真號碼 --
公司網頁 https://www.alkermes.com
員工數量 2050
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Richard F. Pops Chairman of the Board and Chief Executive Officer 美元 1.21M 25/02/2026
Mr. Joshua Reed Senior Vice President and Chief Financial Officer -- 25/02/2026
Mr. Samuel J. Parisi Interim Principal Accounting Officer; Vice President, Finance of Alkermes, Inc. -- 25/02/2026
Mr. Iain M. Brown Senior Vice President, Chief Financial Officer and Principal Accounting Officer 美元 256.72K 05/02/2024
Mr. David Joseph Gaffin Executive Vice President, Chief Legal Officer, Secretary and Chief Compliance Officer 美元 664.56K 07/04/2025
Dr. Craig C. Hopkinson, M.D. Executive Vice President, Research and Development and Chief Medical Officer 美元 742.56K 07/04/2025
Mr. Christian Todd Nichols Senior Vice President and Chief Commercial Officer 美元 596.96K 07/04/2025
Mr. Blair C. Jackson Executive Vice President and Chief Operating Officer 美元 715.00K 25/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Brian P. Mckeon Independent Director 25/02/2026
Dr. Cato T. Laurencin,M.D.,PhD Independent Director 25/02/2026
Mr. Richard F. Pops Chairman of the Board and Chief Executive Officer 25/02/2026
Mr. Frank Anders Wilson Lead Independent Director 25/02/2026
Mr. Shane M. Cooke Independent Director; Chairman of the Board of Alkermes Pharma Ireland Limited 25/02/2026
Ms. Nancy S. Lurker Independent Director 25/02/2026
Dr. Nancy L. Snyderman, F.A.C.S.,M.D. Independent Director 25/02/2026
Dr. Richard Brian Gaynor, M.D. Independent Director 25/02/2026
Dr. Christopher I. Wright, M.D.,PhD Independent Director 25/02/2026
 
所屬ETF (更新日期: 07/03/2026 04:29)
代號 名稱 佔比% 持有日期
JSMLJanus Henderson Small Cap Gr Alpha ETF0.05%27/02/2026
FHLCFidelity MSCI Health Care ETF0.04%28/02/2026
AVSCAvantis US Small Cap Equity ETF0.04%28/02/2026
TMSLT. Rowe Price Small-Mid Cap ETF0.04%28/02/2026
BBMCJPMorgan BetaBuilders US Mid Cap Eq ETF0.04%27/02/2026
EZMWisdomTree U.S. MidCap Earnings ETF0.04%27/02/2026
VFQYVanguard US Quality Factor ETF0.04%31/12/2025
RWJInvesco S&P SmallCap 600 Revenue ETF0.04%27/02/2026
GSCGoldman Sachs Small Cap Equity ETF0.03%27/02/2026
RVTRoyce Small-Cap Trust0.03%31/12/2025
SIXSETC 6 Meridian Small Cap Equity ETF0.03%27/02/2026
PSILAdvisorShares Psychedelics ETF0.03%27/02/2026
ONEQFidelity Nasdaq Composite ETF0.03%27/02/2026
DFUSDimensional US Equity Market ETF0.03%27/02/2026
IWViShares Russell 3000 ETF0.03%28/02/2026
JHSCJHancock Multifactor Small Cap ETF0.03%27/02/2026
FNDCSchwab Fundamental International SmEqETF0.03%28/02/2026
SMMViShares MSCI USA Sm-Cp Min Vol Fctr ETF0.02%28/02/2026
VFMFVanguard US Multifactor ETF0.02%31/12/2025
ESGVVanguard ESG US Stock ETF0.02%31/01/2026
  1    2   3    4    5    6    7    8  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.